Filing summary: First Light Acquisition Group, Inc. (FLAG)
Important identity note: The supplied filing is FLAG’s Form 10-Q for the quarter ended March 31, 2023, not a Form 10-Q filed by Calidi Biotherapeutics. It reports on FLAG, a blank-check company that had signed a proposed merger agreement with Calidi.
Business context and reporting period
FLAG had no operating business or operating revenue through March 31, 2023; its activities were formation, its 2021 IPO, and pursuing a business combination. On January 9, 2023, FLAG agreed to merge with Calidi, subject to shareholder approvals and other closing conditions. The filing describes an agreed Calidi equity value of $250 million, subject to net-debt and other adjustments. The merger had not closed as of the reporting date.
FLAG’s business-combination deadline had been extended to June 14, 2023; the filing describes a remaining extension that could extend the deadline to September 14, 2023, subject to the applicable terms.
Financial performance and position
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Operating revenue | None reported | None reported |
| Operating costs | $2.03 million | $0.53 million |
| Net income (loss) | $(2.22) million | $1.46 million |
| Operating cash flow | $192,286 provided | $465,131 used |
| Ending operating cash | $82,828 | $597,522 |
Q1 2023 results included $425,850 of trust-account earnings, a $27,986 unrealized trust-securities gain, an $88,500 gain from the change in warrant fair value, a $554,443 loss from the change in forward-purchase liability fair value, a $101,404 loss from the change in contingent-interest liability fair value, and $65,475 of income tax provision. No operating margins are meaningful because FLAG reported no operating revenue.
At March 31, 2023, total assets were $43.18 million, including $42.91 million held in the trust account. Total liabilities were $8.15 million, including $6.62 million of current liabilities; working capital deficit was $6.35 million. Related-party promissory notes were outstanding, with the balance-sheet amount reported net of debt discount at $1.46 million. Separately, the notes disclose $490,000 of sponsor/Metric notes and $990,000 drawn under other promissory notes. The filing reports no long-term debt.
Changes versus the prior comparable period
- FLAG moved from $1.46 million net income in Q1 2022 to a $2.22 million net loss in Q1 2023. Operating costs rose by about $1.50 million.
- The prior-year quarter benefited from a $2.09 million gain in warrant fair value; the corresponding Q1 2023 gain was $88,500. Q1 2023 also recorded larger losses on the forward-purchase and contingent-interest liabilities.
- Operating cash increased by $11,064 during Q1 2023, versus a $465,131 decrease in Q1 2022. Q1 2023 operating cash flow was positive largely alongside increases in accrued expenses and other payables.
- Trust-account assets increased from $42.45 million at year-end 2022 to $42.91 million at March 31, 2023. Redeemable Class A shares remained at 4,128,024 following 2022 redemptions.
Merger, outlook, risks, and unusual items
- The merger agreement provides for consideration based on Calidi’s $250 million equity value, subject to adjustment. It also provides potential milestone-related consideration and up to 18 million aggregate escalation shares tied to post-closing share-price thresholds over five years.
- Franklin’s forward-purchase agreement had contemplated a $50 million purchase, but Franklin was not obligated to fund it for the Calidi transaction and informed FLAG it would not purchase the shares in connection with the merger. Do not treat the contemplated amount as committed transaction financing.
- FLAG reported substantial doubt about its ability to continue as a going concern for one year from the financial-statement issuance date. It had $82,828 of operating cash and a $6.35 million working-capital deficit. Sponsor support for working-capital loans was described as a commitment without a formal agreement.
- FLAG reported no formal merger-closing guidance. Completion depended on shareholder approval and other conditions; failure to complete a business combination by the deadline would lead to winding up and redemption of public shares under the stated terms.
- Disclosure controls were deemed ineffective because of a previously disclosed material weakness involving derivative accounting and cash-flow statement presentation, attributed to insufficient trained accounting personnel. Management described remediation efforts but gave no assurance they would succeed.
- The filing cites risks from inflation, higher interest rates, the Russia-Ukraine war, and possible instability in the financial-services sector. It says FLAG had no deposits at the specifically named failed banks, but its funds exceeded FDIC insurance limits.
- The $8.05 million deferred underwriting fee had been waived in December 2022. Q1 fair-value changes in derivative liabilities and the related-party note terms materially affected reported results.
Key facts for investors to verify
- Whether the merger closed, the final redemption level, and the cash available to the combined company; this filing does not establish closing outcomes.
- The final merger consideration adjustments, including net debt, any qualifying pre-closing milestone contracts, and the treatment of escalation and non-redeeming shareholder shares.
- Committed financing at closing, given Franklin’s decision not to fund the forward purchase and FLAG’s going-concern warning.
- The terms, accrued interest, repayment timing, and potential conversion features of outstanding promissory notes.
- Progress in remediating the disclosed material weakness and improving disclosure controls.